Drugs / TEV-45478
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02769091 | Sep 2016 → Jan 2018 | metabolic dysfunction-associated steatohepatitis, type 2 diabetes mellitus | Teva Branded Pharmaceutical Products R&D, Inc. | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TEV-45478 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02769091 ↗ |